NYSE: FMCFmc Corp Stock
$56.58-0.61 (-1.07%)
Updated Dec 6, 2024
FMC Price
$56.58
Fair Value Price
N/A
Market Cap
$7.06B
52 Week Low
$50.03
52 Week High
$68.72
P/E
4.87x
P/B
1.53x
P/S
1.98x
PEG
N/A
Dividend Yield
4.1%
Revenue
$4.17B
Earnings
$1.46B
Gross Margin
37.4%
Operating Margin
4.82%
Profit Margin
34.9%
Debt to Equity
1.65
Operating Cash Flow
$564M
Beta
0.98
Next Earnings
Feb 3, 2025
Ex-Dividend
N/A
Next Dividend
N/A
FMC Overview
FMC Corporation is a chemical manufacturer. Offerings include insecticides, herbicides, fungicides, biologicals, crop nutrition, and seed treatment products to enhance crop yield and quality by controlling a range of insects, weeds, and diseases. FMC was founded in 1883 and is headquartered in Philadelphia, PA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FMC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
D
Momentum
C
Sentiment
A
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Agricultural Input
Industry Rating
D
FMC
Ranked#5 of 15
Ranked#5 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $4.98 | B | |
| $88.44 | B | |
| $77.11 | B |
Be the first to know about important FMC news, forecast changes, insider trades & much more!
FMC News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FMC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FMC is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FMC is good value based on its earnings relative to its share price (4.87x), compared to the US market average (29.86x)
P/E vs Market Valuation
FMC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more FMC due diligence checks available for Premium users.
Valuation
FMC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
4.87x
Industry
30.84x
Market
29.86x
FMC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FMC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
FMC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.53x
Industry
1.37x
FMC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FMC's financial health
Profit margin
Revenue
$1.1B
Net Income
$65.0M
Profit Margin
6.1%
FMC's Earnings (EBIT) of $200.70M... subscribe to Premium to read more.
Interest Coverage Financials
FMC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.2B
Liabilities
$7.6B
Debt to equity
1.65
FMC's short-term assets ($5.32B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FMC's short-term assets ($5.32B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FMC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FMC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$141.2M
Investing
-$16.3M
Financing
-$186.2M
FMC's operating cash flow ($564.40M)... subscribe to Premium to read more.
Debt Coverage Financials
FMC vs Agricultural Input Stocks
Fmc Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.